Vincristine pharmacodynamics and pharmacogenetics in children with cancer: A limited-sampling, population modelling approach

Importance of Shrinkage in Empirical Bayes Estimates for Diagnostics: Problems and Solutions

(2009) Radojka M. Savic et al.   AAPS Journal

Facilitation of Drug Evaluation in Children by Population Methods and Modelling†

(2009) Michel Tod et al.   CLINICAL PHARMACOKINETICS

Vincristine: Can its therapeutic index be enhanced?

(2009) Andrew Moore et al.   PEDIATRIC BLOOD & CANCER

Vincristine pharmacokinetics is related to clinical outcome in children with standard risk acute lymphoblastic leukemia

(2008) Gudmar Lönnerholm et al.   BRITISH JOURNAL OF HAEMATOLOGY

CYP450 pharmacogenetics for personalizing cancer therapy

(2008) Ron H.N. van Schaik   DRUG RESISTANCE UPDATES

Optimizing antifungal drug dosing and monitoring to avoid toxicity and improve outcomes in patients with haematological disorders

(2008) L. J. Worth et al.   INTERNAL MEDICINE JOURNAL

Apparent High CYP3A5 Expression Is Required for Significant Metabolism of Vincristine by Human Cryopreserved Hepatocytes

(2008) J. B. Dennison et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Effect of race on vincristine-associated neurotoxicity in pediatric acute lymphoblastic leukemia patients

(2007) Jamie L. Renbarger et al.   PEDIATRIC BLOOD & CANCER